Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs ; volume:20 ; number:1 ; day:26 ; month:8 ; year:2020 ; pages:1-12 ; date:12.2020
BMC health services research ; 20, Heft 1 (26.8.2020), 1-12, 12.2020
- Creator
-
Mata-Cases, M.
Mahon, J.
Mauricio, D.
Franch-Nadal, J.
Real, J.
Hex, N.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12913-020-05360-w
- URN
-
urn:nbn:de:101:1-2020101419510045306181
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mata-Cases, M.
- Mahon, J.
- Mauricio, D.
- Franch-Nadal, J.
- Real, J.
- Hex, N.
- SpringerLink (Online service)
Other Objects (12)
Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications
Effect of glycaemic control on complications following cardiac surgery: literature review
Superficial Femoral Artery Calcification Is a Novel Risk Factor of Microvascular Complications in T2DM Patients
Differences in mtDNA haplogroup distribution among 3 Jewish populations alter susceptibility to T2DM complications
Reducing the impact of insulin sensitivity variability on glycaemic outcomes using separate stochastic models within the STAR glycaemic protocol
Liraglutide and Glycaemic Outcomes in the LEADER Trial
Quantifying the effect of complications on patient flow, costs and surgical throughputs
The pathophysiology of glucose intolerance in newly diagnosed, untreated T2DM
Costs of diabetes and its complications in Poland
Glycaemic Control in Diabetes
The combined effect of the T2DM susceptibility genes is an important risk factor for T2DM in non-obese Japanese: a population based case-control study
C(− 106)T polymorphism in ALR2 and risk of microvascular complications in T2DM patients in north Indian population
Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications
Effect of glycaemic control on complications following cardiac surgery: literature review
Superficial Femoral Artery Calcification Is a Novel Risk Factor of Microvascular Complications in T2DM Patients
Differences in mtDNA haplogroup distribution among 3 Jewish populations alter susceptibility to T2DM complications
Reducing the impact of insulin sensitivity variability on glycaemic outcomes using separate stochastic models within the STAR glycaemic protocol
Liraglutide and Glycaemic Outcomes in the LEADER Trial
Quantifying the effect of complications on patient flow, costs and surgical throughputs
The pathophysiology of glucose intolerance in newly diagnosed, untreated T2DM
Costs of diabetes and its complications in Poland
Glycaemic Control in Diabetes
The combined effect of the T2DM susceptibility genes is an important risk factor for T2DM in non-obese Japanese: a population based case-control study
C(− 106)T polymorphism in ALR2 and risk of microvascular complications in T2DM patients in north Indian population
Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications
Effect of glycaemic control on complications following cardiac surgery: literature review
Superficial Femoral Artery Calcification Is a Novel Risk Factor of Microvascular Complications in T2DM Patients
Differences in mtDNA haplogroup distribution among 3 Jewish populations alter susceptibility to T2DM complications
Reducing the impact of insulin sensitivity variability on glycaemic outcomes using separate stochastic models within the STAR glycaemic protocol
Liraglutide and Glycaemic Outcomes in the LEADER Trial
Quantifying the effect of complications on patient flow, costs and surgical throughputs
The pathophysiology of glucose intolerance in newly diagnosed, untreated T2DM
Costs of diabetes and its complications in Poland
Glycaemic Control in Diabetes
The combined effect of the T2DM susceptibility genes is an important risk factor for T2DM in non-obese Japanese: a population based case-control study